Xopenex

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
NDA020837 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xopenex (Levalbuterol Hcl) Inhalation Solution Concentrate Is Indicated For The Treatment Or Prevention Of Bronchospasm In Adults, Adolescents, And Children 6 Years Of Age And Older With Reversible Obstructive Airway Disease. Xopenex (Levalbuterol Hydrochloride) Inhalation Solution Concentrate Is A Beta 2 -Adrenergic Agonist Indicated For: Treatment Or Prevention Of Bronchospasm In Adults, Adolescents, And Children 6 Years Of Age And Older With Reversible Obstructive Airway Disease. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levalbuterol Hydrochloride LEVALBUTEROL HYDROCHLORIDE ZINC20230

Comments